Skip to content

The role of imaging in Parkinson*s disease subtypes: a pilot study .

The role of imaging in Parkinson*s disease subtypes: a pilot study . - Imaging in Parkinson*s disease subtypes.

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35081
Enrollment
10
Registered
2010-06-08
Start date
2010-04-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: PD patients must fulfill the United Kingdom Parkinson*s Disease Society Brain Bank criteria for idiopathic PD. PD patients must be allocated to subtype 4 based on their clinical scores. A minimum age of 18 years is required for both patients and control subjects.

Exclusion criteria

Exclusion criteria: Control subjects with a disease of the central nervous system. Participants with a contraindication for MRI.

Design outcomes

Secondary

MeasureTime frame
Not applicable.

Primary

MeasureTime frame
The main study parameters of this study will include clinical and magnetic resonance imaging (MRI) parameters. Clinical data include important demographic and disease-related characteristics as well as measures for disease severity, and the important motor (motor functioning and motor complications) and non-motor domains (cognition, depression, psychotic symptoms, depression, sleep problems, and autonomic dysfunction). The combination of clinical scores allocates patients in one of the four subtypes, and in this study, only patients allocated in the most severe PD subtype 4 are participating. The MRI measures will include volumetric, diffusion, and functional MRI.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)